Octamer factors exert a dual effect on the IL-2 and IL-4 promoters

Journal of Immunology

Volumn 153, Issue 12, 1994, Pages 5572-5585

  Pfeuffer, Isolde ^a,d   Klein Heßling, Stefan ^a   Heinfling, Annette ^a   Chuvpilo, Sergei ^a   Escher, Cornelia ^a   Brabletz, Thomas ^a,e   Hentsch, Bernd ^a,f   Schwarzenbach, Heidi ^b   Matthias, Patrick ^b   Serfling, Edgar ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CHIMERIC PROTEIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 4; NUCLEAR PROTEIN; RECOMBINANT DNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA STRUCTURE; DNA TRANSFECTION; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028034556     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Rao, A. 1991. Critical Rev. Immunol. 10:495.
2. Kamps, M. P., L. Corcoran, J. H. LeBowitz, and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10:5464.
3. Schöler, H. R. 1991. Octamania: The POU factors in murine development. Trends Genet. 7:323.
4. Staudt, L. M., and M. J. Lenardo. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:373.
5. Kang, S. M., W. Tsang, S. Doll, P. Scherle, H. S. Ko, A. Tran, M. J. Lenardo, and L. M. Staudt. 1992. Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Mol. Cell. Biol. 12:3149.
6. Cockerill, P. N., and S. P. Klinken. 1990. Octamer-binding proteins in diverse hemopoietic cells. Mol. Cell. Biol. 10:1293.
7. Staudt, L. M., R. G. Clerc, H. Singh, J. H. LeBowitz, P. A. Sharp, and D. Baltimore. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241:577.
8. Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353.
9. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95.
10. Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108.
11. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion leads to different functional properties. Annu. Rev. Immunol. 7:145.
12. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12:A49.
13. Abe, K., R. D. W. Malefyt, I. Matsuda, K. Arai, and N. Arai. 1992. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 89:2864.
14. Todd, M. D., M. J. Grusby, J. A. Lederer, E. Lacy, A. H. Lichtman, and L. H. Glimcher. 1993. Transcription of the interleukin-4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1663.
15. Li-Weber, M., H. Krafft, and P. H. Krammer. 1993. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 151:1371.
16. Bruhn, K. W., K. Nelms, J.-L. Boulay, W. E. Paul, and M. J. Lenardo. 1993. Molecular dissection of the mouse interleukin-4 promoter. Proc. Natl. Acad. Sci. USA 90:9707.
17. Tara, D., D. L. Weiss, and M. A. Brown. 1993. An activation-responsive element in the murine IL-4 gene is the site of an inducible DNA-protein interaction. J. Immunol. 151:2617.
18. Szabo, S. J., J. S. Gold, T. L. Murphy, and K. M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:4793.
19. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Serfling. 1993. Multiple closely-linked NFAT/ Octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21:5694.
20. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202.
21. Siebenlist, U., D. B. Durand, P. Bressler, N. J. Holbrook, C. A. Norris, M. Kamoun, J. A. Kant, and G. R. Crabtree. 1986. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol. Cell. Biol. 6:3042.
22. Serfling, E., R. Barthelmäs, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:465.
23. 40. Science 254:558.
24. Serfling, E., T. Brabletz, and I. Pfeuffer. 1991. The role of octamer factors in the development and activation of T lymphocytes. Cold Spring Harbor Symposium on Eukaryotic mRNA Transcription, p. 186.
25. Brabletz, T., I. Pfeuffer, E. Schorr, F. Siebelt, T. Wirth, and E. Serfling. 1993. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical Octamer-binding site. Mol. Cell. Biol. 13:1155.
26. Ullman, K. S., J. P. Northrop, A. Admon, and G. R. Crabtree. 1993. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Dev. 7:188.
27. Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun protooncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875.
28. Ryder, K., L. F. Lau, and D. Nathans. 1988. A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl. Acad. Sci. USA 85:1487.
29. Hirai, S.-I., R. P. Ryseck, F. Mechta, R. Bravo, and M. Yaniv. 1989. Characterization of junD: a new member of the jun protooncogene family. EMBO J. 8:1433.
30. Zerial, M., L. Toschi, R. P. Ryseck, M. Schuermann, R. Müller, and R. Bravo. 1989. The product of a novel growth factor-activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J. 8:805.
31. Schuermann, M. 1990. An expression vector system for stable expression of oncogenes. Nucleic Acids Res. 18:4945.
32. Kemler, I., E. Bucher, K. Seipel, M. M. Müller-Immerglück, and W. Schaffner. 1991. Promoters with the octamer DNA motif (AT GCAAAT) can be ubiquitous or cell type-specific depending on binding activity of the octamer site and oct-factor concentration. Nucleic Acids Res. 19:237.
33. Müller, M. M., S. Ruppert, W. Schaffner, and P. Matthias. 1988. A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature 336:544.
34. Randak, C., T. Brabletz, M. Hergenröther, I. Sobotta, and E. Serfling. 1990. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J. 87:2529.
35. Luckow, B. and G. Schütz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
36. Gerster, T., P. Matthias, M. Thali, J. Jiricny, and W. Schaffner. 1987. Cell-type specificity elements of the immunoglobulin heavy chain gene enhancer. EMBO J. 6:1323.
37. Field, J., J. Nikawa, D. Broek, B. MacDonald, L. Rodgers, I. A. Wilson, R. Lerner, and M. Wigler. 1988. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8:2159.
38. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31.
39. Blanar, M. A., and W. J. Rutter. 1992. Identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 256:1014.
40. McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NF-ATp. Science 262:750.
41. Kuwabara, M. D., and D. S. Sigman. 1987. Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthrolin-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. Biochemistry 26:7234.
42. Truss, M., G. Chalepakis, and M. Beato. 1990. Contacts between steroid receptors and thymines in DNA: An interference method. Proc. Natl. Acad. Sci. USA 87:7180.
43. Bengal, E., L. Ransone, R. Scharfmann, V. J. Dwarki, S. J. Tapscott, H. Weintraub, and I. M. Verma. 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68:507.
44. Hentsch, B., A. Mouzaki, I. Pfeuffer, D. Rungger, and E. Serfling. 1992. The weak, fine-tuned binding of ubiquitous transcription factors to the IL-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 20:2657.
45. Rooney, J. W., M. R. Hodge, P. G. McCaffrey, A. Rao, and L. H. Glimcher. 1994. A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J. 13:625.
46. Angel, P., M. Imagawa, R. Chiu, P. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729.
47. Brabletz, T., I. Pietrowski, and E. Serfling. 1991. The immuno-suppressives FK 506 and Cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res. 19:61.
48. Yaseen, N. R., A. L. Maizel, F. Wang, and S. Sharma. 1993. Comparative analysis of NF-AT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J. Biol. Chem. 268:14285.
49. Stern, S., and W. Herr. 1991. The herpes simplex virus transactivator VP16 recognizes the Oct-1 homeo domain: evidence of a homeo domain recognition subdomain. Genes Dev. 5:2555.
50. Verrijzer, C. P., J. A. W. M. van Oosterhout, and P. van der Vliet. 1992. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. Mol Cell. Biol. 12:542.
51. Voss, J. W., L. Wilson, and M. G. Rosenfeld. 1991. POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev. 5:1309.
52. Brunvand, M. W., A. Krumm, and M. Groudine. 1993. In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells. Nucleic Acids Res. 21:4824.
53. Garrity, P. A., D. Chen, E. V. Rothenberg, and B. J. Wold. 1994. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 14:2159.
54. Jain, J., V. E. Valge-Archer, and A. Rao. 1992. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148:1240.
55. Kang, S.-M., B. Beverly, A. C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134.
56. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356:801.
57. Owaki, H., R. Varma, B. Gillis, J. T. Bruder, U. R. Rapp, L. S. Davis, and T. D. Geppert. 1993. Raf-1 is required for T cell IL2 production. EMBO J. 12:4367.
58. ras and calcineurin synergize to regulate the nuclear factor of activated T cells. J. Exp. Med. 178:1517.
59. Cockerill, P., F. F. Shannon, A. G. Bert, G. R. Ryan, and M. A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90:2466.
60. Davies, K., E. C. TePas, D. G. Nathan, and B. Mathey-Prevot. 1993. Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. Blood 81:928.
61. Park, J.-H., K. Kaushansky, and L. Levitt. 1993. Transcriptional regulation of interleukin 3 (IL3) in primary human T lymphocytes. J. Biol. Chem. 268:6299.
62. Hoppe-Seyler, F., K. Butz, and H. zur Hausen. 1991. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol. 65:5613.